Thor Rollins, consulting manager, and Audrey Turley, research scientist, have been invited to speak at the joint conference of the Association of Analytical Communities Southern California Section (AOAC SCS) and Food and Drug Agency (FDA) 2016 Spring Conference. Rollins and Turley will be presenting the morning of Wednesday, April 27 at Chapman University, School of Pharmacy, Irvine. Click here for the full agenda.
Rollins will be presenting on the application of chemical characteristics to medical devices. His presentation will cover how the industry is taking extractible and leachable applications and applying them to medical devices. The discussion will focus on what the challenges are, what benefits they have, where we are right now with the program and speculate about what these applications mean to the future of medical devices.
“I am excited for the opportunity to contribute to the discussion with colleagues and FDA experts about the future of the science behind biocompatibility and medical devices,” said Thor Rollins.
Turley will be presenting on in vitro alternatives to traditional animal testing. Specifically, she will be talking about in vitro irritation, sensitization and thrombogencity.
Visit the Nelson Labs website to view recent presentations by Rollins, How to Use Biocompatibility to Evaluate Changes in Medical Devices, and Turley, New Approaches to Assessing Biocompatibility for Medical Devices.